ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Dryasachip
|
476 |
108K |
7 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
476
|
108K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Dryasachip
|
476 |
108K |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
476
|
108K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Dryasachip
|
476 |
108K |
3 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
476
|
108K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Dryasachip
|
476 |
108K |
24 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
476
|
108K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Dryasachip
|
476 |
108K |
44 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
476
|
108K
|
44
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Dryasachip
|
32K |
15M |
0 |
02/06/24 |
02/06/24 |
Charts
|
32K
|
15M
|
0
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
Dryasachip
|
24 |
5.8K |
11 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
5.8K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
TOP 100 PAAO HOLDERS AS AT 31/05/24
|
|
Dryasachip
|
24 |
5.8K |
24 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
24
|
5.8K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Dryasachip
|
85 |
20K |
42 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
42
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Executive team strengthened, appointment of MD/CEO & new CSO
|
|
Dryasachip
|
85 |
20K |
13 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
85
|
20K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
Dryasachip
|
476 |
108K |
9 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
476
|
108K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Dryasachip
|
58 |
15K |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
58
|
15K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman
|
|
Dryasachip
|
58 |
15K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
58
|
15K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor update
|
|
Dryasachip
|
86 |
20K |
26 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
86
|
20K
|
26
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
6 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
7 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
4 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
22 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Dryasachip
|
83 |
24K |
10 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
83
|
24K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Dryasachip
|
83 |
24K |
13 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
83
|
24K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Dryasachip
|
83 |
24K |
24 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
83
|
24K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Dryasachip
|
83 |
24K |
8 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
83
|
24K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Dryasachip
|
239 |
63K |
12 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
239
|
63K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Dryasachip
|
239 |
63K |
11 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
239
|
63K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Dryasachip
|
239 |
63K |
5 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
63K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
14 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Dryasachip
|
239 |
63K |
36 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
239
|
63K
|
36
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Dryasachip
|
239 |
63K |
36 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
239
|
63K
|
36
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
Dryasachip
|
239 |
63K |
41 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
63K
|
41
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
10 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
12 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.4K
|
358K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
Dryasachip
|
104 |
20K |
6 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
104
|
20K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
10 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
261
|
71K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
9 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
71K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
13 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
71K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
12 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
71K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
8 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
71K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
28 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
261
|
71K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
22 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
71K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Dryasachip
|
261 |
71K |
5 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
71K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Dryasachip
|
32 |
9.8K |
2 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
32
|
9.8K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Dryasachip
|
37 |
9.3K |
23 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
37
|
9.3K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Dryasachip
|
37 |
9.3K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
9.3K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Dryasachip
|
317 |
81K |
21 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
317
|
81K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Dryasachip
|
317 |
81K |
21 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
317
|
81K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Dryasachip
|
32 |
9.8K |
6 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
32
|
9.8K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Dryasachip
|
100 |
27K |
8 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
100
|
27K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Dryasachip
|
1.4K |
358K |
13 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.4K
|
358K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
Dryasachip
|
32 |
9.8K |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
32
|
9.8K
|
5
|
|